SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " Guardian " 649 found 🔀 AI-powered Shuffle
Nigel Farage is just one strand in the tangle of rightwing politicians and crypto investors
These financiers want to remodel the UK into a form that suits them – one that could threaten to erode the barriers between crime and business, says Guardian columnist John Harris
Los Angeles Air Force Base Kicks off Sports Day 2026
On July 1, 2026, Members of Los Angeles Air Force Base came together for the highly anticipated annual sports day. The event brought together Airmen, Guardians, and contractors, drawing them away from their daily operations to unite under a shared goal. This friendly competition not only promoted health and wellness but also fostered camaraderie outside the traditional workplace environment.
Guardians News: On to Minnesota
News and Notes for Tuesday, July 7th, 2026
Half of Americans struggle to afford groceries and gas, exclusive poll finds
About 57% of polled Americans also believe economy is worsening in grim portrait of cost of living crisis, according to Harris survey for the Guardian
Northern Trust sells $1.2B guardianship business to Wintrust
The deal boosts Wintrust’s assets under management in its wealth management business by $1.2 billion.
Guardians Lose 3-1 To White Sox
This was a pretty underwhelming game from the offense. They faced a good pitcher in Burke, but boy did they make him look great. A solo HR from Hedgey in the 5th is the only thing that kept this one from being a shutout. Hedges is now hitting .281 with a .756 OPS on the […]
Guardians Complete Trade With Phillies for Pitching Prospect
Elon Musk posted twice as often on UK race and immigration as about SpaceX in IPO run-up
Guardian analysis of X feed shows how keen world’s richest person was to air his views and ‘interfere’ in British politics
Americans disgusted at Trump earning $1bn from crypto as president: ‘Obviously a grift’
Hundreds of Guardian readers expressed concerns over greed in the White House and a billionaire president unconcerned with high gas and grocery prices
The Guardian view on xenophobic violence in South Africa: anti-migrant politics can’t fix domestic problems
Editorial: Foreigners are not to blame for unemployment, crime and the state of public services. Leaders should have the courage to say so more clearly
They say Andy Burnham is ‘good at politics’ – but the proof will only come in time
The PM-in-waiting brings the promise of likability and a mission voters can believe in. He’ll need all that and more to survive, says Guardian columnist Zoe Williams
Brand New The Blood of Dawnwalker Gameplay Showcases Coen’s Investigation Skills and a Boss Battle Against the Eerie Forgotten Guardian
See Coen's investigation and fighting skills on full display in this quest gameplay from The Blood of Dawnwalker.
Cleveland Guardians’ Rookie Kahlil Watson Flashing Major League Tools
Cleveland Guardians rookie outfielder Kahlil Watson has shown power, speed, a good hit tool, and solid defense after his graduation to the major league club
Guardians rookie Cooper Ingle tosses ball into stands early after losing outs count in loss to Rangers: 'I feel terrible'
The Guardians 2026 Trade Deadline Manifesto
Surveying the landscape a month ahead of the deadline
Ahead of the MLB trade deadline, here’s where the Guardians stand
The Guardians are among the best teams in a weak American League. This is the time for them to capitalize on their situation.
'Nobody likes you': Argument between former teammates Josh Naylor and Austin Hedges gets personal in Mariners-Guardians
Cleveland Takes Series from Seattle in Sunday Victory
Seattle Mariners 5 - Cleveland Guardians 6
Guardians score, lineups vs Seattle Mariners at Progressive FIeld
The short-handed Guardians look to find some offense against the Mariners at Progressive Field. Follow along here for live updates.
Making Our Own Luck
We are cross-posting a piece that former NIH official Kris Willis wrote for Macroscience. Kris is now the President and Founder of the Woodley Park Institute, for which I’m a board member. Picking winners or hedging bets? Federal science agencies have long wrestled with the question of how to ensure their billions of dollars of grants and contracts result in maximum benefits for Americans. On the surface, it might seem that a goal-oriented, interventionist style of management would be the best policy: prioritize our most pressing problems and distribute funding accordingly.This top-down strategy creates a unique hazard, though: bad choices can send resources in the wrong direction, resulting in slow progress that impedes the delivery of tangible benefits to citizens. Moreover, if decision makers pursue an applied advance when the underlying scientific principles remain poorly understood, they risk costly failures and a loss of support for the research enterprise at large. Examples include Nixon’s 1971 War on Cancer, undertaken on the premise that a cure could be achieved in less than a decade, the drive to build an operational commercial fusion plant by the mid-1990s, and the National Plan to Address Alzheimer’s Disease, which failed to produce the effective treatments and prevention strategies promised by 2025. The contrasting laissez-faire approach is to hedge your bets. If the path to an advance is impossible to predict, then the wisest choice might be to distribute funding to as widely as possible. The main risk of this strategy is that spreading funding thinly may limit the resources available to the most promising research, resulting in the same negative outcomes as the interventionist approach: limited support for the most promising topics, slow progress, and delayed returns. In reality, at science agencies like the National Science Foundation and National Institutes of Health, program managers navigate between these two extremes, setting some funds aside to target high-priority areas and using the rest to cover the widest possible range of meritorious proposals. This middle path seems like the most rational way to proceed, but it still requires making choices. How much should be set aside for high priority topics? What should those topics be? How should we define merit? Expert opinion can provide a helpful guide, but leading experts can have remarkably different opinions about what matters and what should be prioritized. Moreover, experts and administrators alike can be risk averse, giving an edge to high-profile, well-established concepts. What’s really needed is a data-driven framework to help guide decision-making, one that doesn’t simply repackage prestige or incumbency. Recognizing breakthroughs years in advance Many breakthroughs fail to attract funding or recognition at the earliest stages of development. Katalin Karikó, for example, spent years struggling to win grants for work on mRNA that would eventually win her and Drew Weissman a Nobel Prize. Similar stories can be told about Jim Allison’s groundbreaking studies leading to the development of cancer immunotherapy, Stan Pruisner’s demonstration that prions can self-replicate without DNA, or Robin Warren and Barry Marshall’s proof that Helicobacter pylori, not stress, causes ulcers. Yet at some point, the scientific community recognizes and responds to transformative breakthroughs like these. How does that change happen? And what if science funders could identify the areas that are on the cusp of a breakthrough? Those questions led my collaborators and me to study how scientists responded to past breakthroughs. Based on patterns in that data, we developed a means of predicting future breakthroughs, using biomedicine as a proof of concept. It’s worth taking a moment to describe how our approach works. Briefly, our prediction process begins by grouping the 18 million or so peer-reviewed papers in PubMed, the authoritative database of biomedical research, into roughly 50,000 unique topics. A small subset of these topics are so widely acclaimed as breakthroughs that they have been recognized with a major prize like a Nobel or a Lasker Award. We theorized that studying the development of these outliers over time, especially before they gained acclaim, was the key to identifying future instances of them. After defining topics, we chose 21 representative breakthroughs and asked what they looked like before they won prestigious prizes. To answer that question, we re-ran our topic-mapping algorithm repeatedly, winding back the clock one year each time, stringing together the years to follow the progress of each field as it grew and advanced. We found that in each case, the years leading up to a discovery followed a pattern: a burst of papers on a new, rapidly evolving topic, many of which quickly became influential. These characteristics—the percent of papers that are new, the percentage of papers that are brought in from other topics, and the influence of each individual paper—can all be measured separately for any given topic. Together, they act as a predictive signal that is detectable an average of five years before a transformative discovery is made, and up to thirty years before the discovery receives a major prize. Scanning the current research landscape for topics that display this signal allows us to predict what work will likely produce a future breakthrough. Each year we analyzed includes four or five signals, a number that appears to have remained constant across a twenty year time frame. In their classic work on the sociology of science, Bruno Latour and Steve Woolgar established that the desire to participate in a major discovery is an important motivator for scientists as they consider whether they should take up (or abandon) a research problem. Although further work is needed, the simplest explanation for our results is that this behavior is widespread enough to detect at scale. A foundational advance, or something like it, draws the attention of scientists and causes them to change the direction of their research. They vote with their feet, staking their own reputation and careers by publishing on and citing the new idea. That upswell of interest is the foundation of our breakthrough signal. What kind of research does our model identify as a breakthrough? After building a model based on the patterns in our 21 preselected breakthroughs, we tested it by identifying all early signals of discovery from 1994 through 1997. Of the 18 signals we found in that time period, 17 can be traced forward in time to a breakthrough. Examples include super-resolution fluorescence microscopy (see the image above), the directed evolution of proteins and enzymes (Chemistry Nobel, 2018), and sequencing the human genome (National Medal of Science, 2008). The discovery of the role of leptin signaling in obesity is a particularly interesting case study. Around 1950, scientists noticed the existence of a type of lab mouse that suffered from a unique inherited form of obesity. When given the freedom to choose their own diet, these mice ate more than normal and preferred food that was high in fat. Researchers had few clues as to why the animals overate; early experiments pointed to the existence of a soluble ob factor found circulating in the bloodstream that regulated appetite, but its identity was unknown. In 1994, Jeffrey Friedman and colleagues identified and sequenced the ob gene, noting that the protein it encoded appeared to fit the profile of a circulating factor. A year later, a trio of high-profile publications demonstrated that ob was a hormone that regulated body weight and fat deposition by regulating appetite. One of these was co-authored by Friedman, who christened it leptin from the ancient Greek word for thin. Using our model, the data from 1996 make it clear this advance would become a breakthrough. Scientists had flocked to study the biology of the new hormone, generating the flurry of new papers and citations required to produce a signal. One of these demonstrated that serum leptin concentrations reflected the amount of adipose tissue in the human body, providing clinical validation of the earlier mouse studies. Before the identification of leptin, scientists were unable to point to a specific molecule that controlled appetite and adiposity, so that it was impossible to rule out non-physiological causes of obesity; its characterization fundamentally changed our concept of weight gain. In 2010, Friedman and fellow pioneer Douglas Coleman were awarded a Lasker for the discovery. Our work also identifies breakthroughs in clinical practice and behavioral and social sciences, even though these areas are less likely to draw the attention of major prize committees. One example that falls into this category is the introduction of endovascular aneurysm repair, a minimally invasive surgical procedure for the treatment of abdominal aortic aneurysm, a leading cause of death among Americans over the age of 65. Relative to the previous standard of care, it reduces in-hospital mortality by almost four-fold. In 2017, Timothy Chuter received the American College of Surgeons’ prestigious Jacobsen Innovation award for his multiple refinements to the technique. Another under-recognized breakthrough identified by our model is the development of standardized survey instruments to assess the quality of life for HIV+ patients. The antiretroviral cocktails introduced in the mid-1990s reduced AIDS mortality, but treatment came with serious side effects. The new evaluations showed that patients whose disease progressed had worse physical functioning than Americans with other chronic diseases, while those who were asymptomatic maintained a health-related quality of life on par with the overall US population. This evidence made it possible for patients and activists to argue that even in the absence of a total cure, and in spite of the side effects, alleviation of symptoms was a worthwhile priority for clinicians. My colleagues and I have failed to identify any significant recognition for the physicians and health policy experts who pioneered this advance, although in 2016, researchers called for the World Health Organization to set targets for good health-related quality of life as part of its framework to end the AIDS pandemic. From forecasting to funding How should science funders use our predictions? Any serious discussion of what we should do with this new capability needs to begin with an understanding of its limitations. We can’t (and shouldn’t) invest all of our resources in the small number of topics predicted to produce breakthroughs. Innovative new fields are born from existing ones; they rarely arise de novo. If funders don’t maintain a diverse portfolio, the breakthroughs of tomorrow will have no antecedents. Think of this as eating the seed corn, or killing the goose that lays the golden egg. There are also multiple goals of funding beyond basic scientific discovery, including translating discoveries into clinical practice, developing new technologies, supporting economic development, and training new scientists. The investments needed to accomplish these goals are likely different from those required to support emerging breakthroughs. Finally, we must be aware that we may not capture every instance of a breakthrough. The concept is fuzzy, and not every significant discovery is recognized with a major award. Further, breakthroughs are rare, meaning that our dataset is, by necessity, small. This makes formal estimates of accuracy challenging. Although our overall success rate appears to be high, any one signal may turn out to be a false positive. We found one apparent example: the development of the third generation COX-2 inhibitors, Vioxx and Celebrex, which were much celebrated in the early 2000s as effective but non-addictive pain relievers, meets all the algorithmic criteria of a breakthrough. Five years after it received FDA approval, researchers demonstrated that Vioxx was associated with serious cardiovascular complications, and the manufacturer voluntarily pulled the drug from the market. Celebrex remains available, although like other NSAIDs, it carries an FDA warning for increased cardiovascular risk. Decision makers who were overly focused on the breakthrough potential of this research might have wasted substantial resources nurturing an area that ultimately proved to be a failure—but so would those who relied on expert opinion at the time. That said, the potential benefits of funding the next mRNA vaccine or cancer immunotherapy years earlier than we might have are large. When we can’t assume the outcome of an action, it’s worth conducting an experiment. Can targeted support for areas that are poised to produce a breakthrough increase the return on scientific investment without cannibalizing future advances? With the necessary administrative infrastructure in place, conducting this experiment would be straightforward. First, identify all the breakthrough signals between 2018 and 2023, select half at random, and commit to a decade of investment. For biomedicine, a six year window should yield about 30 topics with the potential to produce a breakthrough. Providing strong support to half of these might be accomplished for $300 million a year. That’s roughly half of the recent annual budget of the NIH Common Fund or around 20% of the fiscal year 2025 budget for ARPA-H. After five years, then again at ten, compare to see which group — the one that was actively managed, or the control — produced more breakthroughs, and on what timescale. Although we used biomedicine as an example, the same experiment could just as well be run for physics, materials science, or any other discipline. Any attempt to undertake such an experiment should keep three points top of mind. First, we can predict the topic of future breakthroughs, but the people and vision for how to move the work forward are still important. In practice, this means success requires active program managers with the expertise to develop the science and the authority to do so, including by recruiting investigators. Second, we would be wise to learn from the failures of past attempts to fund transformative research. High among these are funding modestly repackaged work, confusing the genuinely novel with the merely unfamiliar, and relying too much on incumbent investigators. All of these risks can be mitigated by thoroughly and intelligently integrating high quality data into portfolio management. Finally, we need to have patience. Even with strong funding support, producing a breakthrough takes time. If supporting breakthroughs is the best way to nurture the birth of new fields, we also need to accurately describe and properly manage the other two stages, so that we invest wisely throughout the productive lifetime of ideas and divest once they reach the point of diminishing returns. We would benefit from more study of all of these phases, especially the transition from one to another. More research could answer questions like: When does a breakthrough become an established field? How do the availability of funding, the size and characteristics of the available workforce, and the accumulation of evidence that disagrees with prevailing models affect a field’s decline? Exactly how do old ideas give birth to new ones, and can we speed up the process? The more we understand about the dynamics of scientific progress, the better we can maximize the odds that our curiosity leads to results. I’d call that finding a way to make our own luck.
Stubborn, arrogant, a genius: France’s De Gaulle epic shows up the tepidity of our politics
The man who led Free France during Nazi occupation was single-minded to the point of obstinacy. But he believed in his own power to make history, says Guardian Europe writer Alexander Hurst
Latest Injury Update on Guardians' Chase DeLauter
Chase DeLauter's return to the Cleveland Guardians' lineup might come sooner rather than later.
Keir Starmer has quit as prime minister – what will happen next in UK politics?
Britain will soon have its fifth prime minister in four years. The Guardian explains how we got here and what challenges await Starmer’s successor
Guardians' Joey Cantillo: Leans on curveball
Guardians' Joey Cantillo: Leans on curveball
Astros vs Guardians Game Discussion: 6/19/2026
Game Info Game Date/Time: Friday, June 19, 7:10 p.m. CT Location: Daikin Park, Houston, TX TV: Space City Home Network Radio: KBME 790 AM & 94.5 FM HD2; TUDN 102.9 FM HD2 (Spanish)
Tired with Iran, Trump refocuses on Ukraine
Jenna Amatulli speaks to the Guardian’s Andrew Roth about the chances this peace deal will succeed, and why Trump is turning his attention back to Ukraine
Brewers drop series finale to Guardians, 4-2
Bullpen squanders lead as offense fails to come through with big hit late
Guardian Resilience Teams promote holistic health, culture of fitness
Central to U.S. Space efforts are a transition from traditional fitness models to Holistic Health Approach, an integrated and preventative approach that prioritizes the enduring health, performance and resilience of Guardians.
Brewers Make Long Awaited Call-Up
After signing a massive pre-debut contract, elite prospect Cooper Pratt heads to Milwaukee to bolster the Brewers' lineup with speed and defense against the surging Cleveland Guardians.
The Relic: First Guardian launches July 31 for PS5 and PC, later this summer for Xbox Series and Switch 2
Dark fantasy Soulslike action RPG The Relic: First Guardian will launch for PlayStation 5 and PC via Steam on July 31, followed by Xbox Series and Switch 2l later this summer, publisher Perp Games …
Detroit Tigers series finale rained out vs Cleveland Guardians
The Detroit Tigers' game Sunday, June 14, against the Cleveland Guardians was postponed due to weather, pushing Casey Mize's return from the IL back.
Who will the Guardians be without José Ramírez?
Hello darkness my old friend
Guardians Make Chase DeLauter Announcement After Leaving Tigers Game
The Cleveland Guardians announced an update on rookie outfielder Chase DeLauter.
Tarik Skubal pitches 4 2/3 innings during first Tigers start since elbow surgery, hits 99.9 mph in loss to Guardians
Detroit turned to Skubal for the first time since April 29, and, 38 days after his 'Skubal scope' procedure, he showed some encouraging signs.
Guardians smother Tigers in Tarik Skubal’s return
Skubal looked healthy, but Daniel Schneemann’s two-run homer was the difference.
Anna Faris credits podcast with helping her through Chris Pratt divorce
Anna Faris credited a surprising project with helping her through her 2017 divorce from Chris Pratt.
AIPAC Wants Democrats to Back Israel. Instead, They’re Turning on AIPAC.
Once the guardian of the bipartisan pro-Israel consensus, it is now a polarizing force in the party.
New York Yankees @ Cleveland Guardians: Carlos Rodón vs. Parker Messick
It’s a southpaw showdown as the Yankees go for the sweep.
Michael Meadowcroft obituary
Liberal politician, local councillor and Leeds West MP who turned to journalism, writing for the Times and the Guardian
There are no guardrails now on the right of UK politics: where Restore Britain goes, others will follow
In the UK – and across the west - incendiary language and white supremacist policies are entering the political mainstream, says Guardian columnist Owen Jones
New York Yankees @ Cleveland Guardians: Gerrit Cole vs. Slade Cecconi
The Yankees’ ace looks to bounce back against the team that handed him his first loss in 627 days.
Bellinger plays hero as Yankees outlast Guardians in 10 innings
Paul Goldschmidt homered early, Ryan McMahon stayed hot, and Cody Bellinger delivered the decisive blow as the Yankees survived a tense 10-inning affair.
Rangers' Jacob deGrom: Blanks Guardians across six innings
Rangers' Jacob deGrom: Blanks Guardians across six innings
Joey Cantillo’s Rough Stretch Continues as Guardians Lose to Rangers
Rangers Crush Guardians to Win Series
The Texas Rangers returned the favor against the Cleveland Guardians after a rough game on Saturday.
Guardians' Brayan Rocchio: Clouts homer in win
Guardians' Brayan Rocchio: Clouts homer in win
Confessions of political liveblogger: ‘I enjoy it professionally – but, as a citizen, you can think the country’s going to hell in a handcart’
Andrew Sparrow has been writing the Guardian’s daily political live blog for more 15 years. How does he cope with the relentless psychodrama of British politics?
Guardians Dominate Rangers Behind Bibee’s Gem
The offense came alive tonight but the story of the game was Tanner Bibee’s phenomenal outing. He tossed 8 scoreless innings and had only 87 pitches, I really wish they would’ve game him a chance to complete the Maddux. He lowered his ERA all the way down to 4.09 from this outing. If Bibee can […]
Why the Rangers Were Shut Out
The Texas Rangers did not have an answer against the Cleveland Guardians on Saturday night.
Rangers host the Guardians on 4-game home win streak
The Texas Rangers host the Cleveland Guardians trying to continue a four-game home winning streak
Leaked WhatsApps, embarrassing emails: it’s bad for British politics that privacy is now dead
The principle underlying the release of the Mandelson papers is that officials are always ‘on the record’ – but our leaders must be able to speak their minds freely, says Guardian columnist Simon Jenkins
Game 63 Game Day Thread – Cleveland Guardians @ Texas Rangers
Welcome back, the top two hitters in the lineup
Upstate county's lawmakers push bill holding parents accountable
The bill would require parents or guardians of juvenile offenders to complete mandatory parenting classes. Those who refuse would face community service.
Guardians Make a Statement With Series Win Over Yankees
The Cleveland Guardians asserted themselves as one of the teams in the American League after taking two of three games from the New York Yankees.
A Brit, a billionaire and Spencer Pratt: California’s primary upsets
Jonathan Freedland speaks to the Guardian’s Sam Levin about the big takeaways from the single busiest primary day of the year so far
Guardians Have Decisions to Make as Gabriel Arias Nears Return
Guardians' Patrick Bailey: Exiting starting nine
Guardians' Patrick Bailey: Exiting starting nine
Zombie Blairites still have British politics in their grip – it’s time to break free
Tony Blair’s departure as PM should have prompted a fresh start for Labour. But Starmer’s sad, backward-looking government remains in his thrall, says Guardian columnist Aditya Chakrabortty
Guardians score vs. Yankees. Jose Ramirez powers Cleveland to win
Jose Ramirez continues to thrive at Yankee Stadium and the Guardians guarantee a series win by hitting three home runs to back Gavin Williams.
Guardians' Gavin Williams: Hurt by hard contact in win
Guardians' Gavin Williams: Hurt by hard contact in win
Guardians proving to be a threat to the Yankees, Women’s College World Series preview & an early look at the trade deadline
Guardians' Steven Kwan: Contributes immediately
Guardians' Steven Kwan: Contributes immediately
Guardians News: Judgeless Yankees no match for young team
The Yankees entered Tuesday’s game 3-8 against teams over .500. They did nothing to show they were better than that at home against Cleveland. With the help from some creative argumentative tactics, they came back twice vs Guards SP Joey Cantillo, but they ran out of tricks once he was out of the game. CLE’s […]
Guardians' Kyle Manzardo: Goes deep in Tuesday's win
Guardians' Kyle Manzardo: Goes deep in Tuesday's win
Bazzana’s Bases Clearing Double Secures Victory
Cleveland Guardians 9 - New York Yankees 4
Guardians' Petey Halpin: Returns to Triple-A
Guardians' Petey Halpin: Returns to Triple-A
New York Yankees vs. Cleveland Guardians: Series Preview
The Yankees return home for a clash with the first-place Guardians.
Guardians visit the Yankees to open 3-game series
The New York Yankees host the Cleveland Guardians to open a three-game series
British politics is fractured and chaotic – but at last it’s brimming with ideas for the future
Finally, Labour is talking policy, thanks to the leadership contest and Tony Blair’s intervention – and the centre-right is making a much-needed fightback too, says Guardian columnist Polly Toynbee
"Guardians make their own fate": As a Destiny 3 petition surges, Destiny 2 dev calls on players to log in for its final content update on June 9
Bungie's Destiny 2 community lead is rallying players to log in for its final update Monument of Triumph.
Three Positives From the Week of May 24th
It was not a very positive week for the Guardians, so here are three small moments to smile about.
AI is devoid of meaning and humanity. That’s why its vapid voice suits this political moment
For ease and speed, we are degrading our ability to connect and to organise our societies. We must assert our trust in humans over machines, says Guardian columnist Nesrine Malik
The Guardian view on the Aberdeen South byelection: the politics of energy take centre stage
Editorial: While Westminster’s attention is focused on Andy Burnham and Makerfield, another pivotal byelection is taking place in Scotland’s north-east
Offense Struggles As Guardians Drop Game 2
It was a rough game for the Guardians on Saturday. Travis Bazzana went 2-4 with two doubles, and José Ramírez went 1-3 with an RBI double and a walk. Petey Halpin also went 2-4 with a double. Other than that, it was a really tough day for the offense. I’m not worried about them long […]
Washington Nationals vs Cleveland Guardians Game Thread
Follow along as the Nats look to keep the good times rolling and sweep the Guardians
Travis Kelce becomes a franchise owner. Could Taylor Swift be next?
Kansas City Chiefs star and burgeoning business titan Travis Kelce will be a minority owner in the Cleveland Guardians, the MLB team he rooted for growing up.
Travis Kelce buys minority stake in Cleveland Guardians: Chiefs star joins hometown team's ownership group
Travis Kelce of the Kansas City Chiefs enters the world of MLB ownership with a stake in his hometown Cleveland Guardians.
Chiefs star TE Travis Kelce buys ownership stake in hometown Cleveland Guardians: Source
In 2020, Kelce's teammate Patrick Mahomes joined the ownership group of the Kansas City Royals, the Guardians' division rival.
Travis Kelce buys ownership stake in Cleveland Guardians
Scoop: The Guardian posts record U.S. revenue of $81M
The outlet's nonprofit structure, combined with its global perspective and commitment to free access, has helped usher in an unprecedented level of reader donations.
Guardians lineup today, live score updates vs. Nationals
The Cleveland Guardians host the Washington Nationals on May 25. Follow along for live updates throughout the game tonight.
Three Positives From the Week of May 17th
A near-perfect week for the Guardians helped them extend their lead atop the AL Central.
Reform MP refuses to say whether Farage should produce evidence for Russian hack claim
Danny Kruger says matter is ‘private’, after party leader claimed hack was behind Guardian story about £5m gift
To understand Britain’s new politics, look no further than this Shakespearean saga in Worcestershire
What should be a story of Reform incompetence instead speaks to the broader refusal of Westminster to adapt to multiparty democracy, says assistant Guardian Opinion editor Jason Okundaye
Guardians Announce Roster Move Before Phillies Series Finale
Guardians pitcher Logan Allen returns to the major league roster ahead of Sunday’s series finale against the Phillies.
Guardians score vs. Phillies. Parker Messick pitches Cleveland over Philadelphia
Travis Bazzana belted a solo home run and had three hits and the visiting Cleveland Guardians beat the Philadelphia Phillies on May 24 to win series.
Last Night In Baseball: Brewers Take Game 1 Of 3-Game Series Against Dodgers
The Brewers took Game 1 of a three-game series against the Dodgers, the Guardians beat the Phillies on one swing, the Braves walked it off and plenty more from Friday's MLB action.
Guardians Shutout Phillies in Series Opener Classic
Guardians 1, Phillies 0